Catch up with health and wellness news from Brunei

Provided by AGP

Got News to Share?

Brunei Health Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Brunei Health Wire.

Press releases published on May 20, 2026

Leafwell Advances Medical Cannabis as Clinically Validated Solution for Cancer-Related Symptoms and Chronic Pain, Supports Employer-Sponsored Mental Health Benefits
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
AMA Unveils Infographic to Help Patients Safely Navigate AI in Healthcare
How To Boost Testosterone After 40?| Safe Testosterone Boosters for Men Over 40 and 50 For Muscle Growth, Energy, Stamina and Performance in 2026 – Launched By Testoprime
Ronald McDonald House New England Launches Brand Revitalization, Deepening its Mission to Keep Families Close
Regional Health Properties Reports First Quarter 2026 Results
Tru-1 By BlueGenes Launches to Advance Precision Health Through Smarter Genetic Insights
New Studies Show Adherence to Monthly Injectable Buprenorphine is Associated with Relapse Reduction and Lower Healthcare Utilization
 Alzheimer’s Research Sites Honor National Clinical Trials Day
BioStem Technologies Announces Notice of Allowance for Four U.S. Design Patent Applications Covering Fenestrated Human Placental Allografts and One European Patent
Aeroflow Urology Donates to National Diaper Bank Network and United Way to Improve National Health Equity
JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA
Ernexa Therapeutics Releases Virtual Investor KOL Connect Segment Featuring Dr. Elena Ratner Highlighting Ovarian Cancer Landscape and ERNA-101 Opportunity
PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference
IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Sustainability Leader Ashley McKeon Selected as Soil Health Institute’s President and CEO
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

Share us

on your social networks:

Sign up for:

Brunei Health Wire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.